Rhamnocitrin

2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

Rhamnocitrin is an anti-inflammatory and antioxidant agent that targets STIM-1, NFATc3 and MAPK pathways and can scavenge DPPH (IC50=28.38 mM). Rhamnocitrin selectively inhibits oxidative stress and inflammatory responses in vascular endothelial cells and neurons. Rhamnocitrin up-regulates miR-185 to inhibit STIM-1-mediated store-operated calcium entry (SOCE), thereby blocking NFATc3 nuclear translocation and downstream inflammatory factor expression, while inducing heme oxygenase HO-1 expression and regulating the ERK/p38 MAPK pathway, inhibiting antioxidant and pro-inflammatory cytokines (such as IL-6, IL-8) and adhesion molecules (such as ICAM-1, VCAM-1). Rhamnocitrin can be used in the study of endothelial-related inflammatory diseases (such as sepsis, acute lung injury, atherosclerosis) and neuroprotection (such as oxidative damage of PC12 cells).

For research use only. We do not sell to patients.

  • Purity: 99.29%
  • CAS No.: 569-92-6
  • Formula: C16H12O6
  • Molecular Weight:300.26
  • Storage:

    4°C, protect from light

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Rhamnocitrin

More
Customer Validation & Images
Cell Proliferation/Viability AssayIFFlow CytometryWB
  • Cell Proliferation/Viability Assay
  • IF
  • Flow Cytometry
  • WB
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00